Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow TALPHERA, INC.

Get SEC filing alerts via email and in your feed for TALPHERA, INC.

TLPH

TALPHERA, INC.

About TALPHERA, INC.

Talphera, Inc. is a specialty pharmaceutical company developing innovative therapies for use in medically supervised settings. Its portfolio includes nafamostat-based product candidates for anticoagulation, antiviral, and inflammatory indications, targeting hospital and critical care markets. The company focuses on obtaining regulatory approvals, advancing clinical trials, and commercializing therapies that address unmet medical needs, leveraging proprietary formulations, patents, and strategic partnerships.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from TALPHERA, INC.

1
1
TALPHERA, INC. Talphera, Inc. Reports $2.6 Million Net Loss and No Revenue in Q1 2026

Via official filing (AI summary) | 22 days ago | 0 comments

2
1
TALPHERA, INC. Talphera, Inc. Reports $14.3 Million Net Loss and $28,000 Revenue for Fiscal Year 2025

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
TALPHERA, INC. Talphera, Inc. Reports Q3 2025 Financial Results with Increased Net Loss and Revenue Growth

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
TALPHERA, INC. Talphera, Inc. Reports $3.5 Million Net Loss in Q2 2025, Seeks Additional Capital

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
TALPHERA, INC. Talphera, Inc. Reports First Quarter 2025 Financial Results with Revenue Growth and Reduced Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
TALPHERA, INC. Talphera, Inc. Reports $13M Net Loss for Fiscal Year 2024, Focuses on Niyad Development

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
TALPHERA, INC. Talphera, Inc. Reports Significant Financial Challenges, No Revenue in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments